PLA-695

DRUG3 trials

Sponsors

Wyeth is now a wholly owned subsidiary of Pfizer

Conditions

Arthritis, RheumatoidHealthyOsteoarthritis

Phase 1

Study Evaluating the Gastrointestinal Safety of PLA-695 Compared to Placebo and Naproxen

CompletedNCT00366262

Wyeth is now a wholly owned subsidiary of PfizerHealthy

Start: 2006-06-30End: 2007-03-31Updated: 2008-08-05

Study To Evaluate The Pharmacokinetic Interaction Between PLA-695 And Methotrexate In Adults With Rheumatoid Arthritis

CompletedNCT00440492

Wyeth is now a wholly owned subsidiary of PfizerArthritis, Rheumatoid

Start: 2006-12-31End: 2007-11-30Updated: 2007-12-13

Phase 2

A Study Comparing 4 Dose Regimens of PLA-695, Naproxen, and Placebo In Subjects With Osteoarthritis Of The Knee

TerminatedNCT00396955

Wyeth is now a wholly owned subsidiary of PfizerOsteoarthritis

Start: 2006-11-30End: 2007-11-30Target: 560Updated: 2007-12-28